Infliximab — Powder for concentrate for infusion

المنتج المرجعي للتكافؤ الحيوي · Infliximab

MoleculeInfliximab
Dosage formPowder for concentrate for infusion
Reference comparatorRemicade (Janssen/MSD)
TierA
Recommended BE approachTotality-of-evidence comparability: analytical + functional, PK/PD ± clinical — WHO TRS 1043 Annex 3
NoteBiological — comparability exercise
Illustrative harmonised register entry for the Arab markets. Confirm the definitive comparator with the authority of each market before use.
سجل استرشادي موحد · يلزم تأكيد المقارن النهائي من سلطة كل سوق قبل الاستخدام.

Search the interactive Register (375 entries) · the full table · how to cite

Share: LinkedIn · X · WhatsApp · Telegram · Email

Cite as: AUPAM Experts' Office, Infliximab (Powder for concentrate for infusion) — bioequivalence reference product — AUPAM Register, retrieved 2026-08-31, https://aupameo.org/datasets/register/infliximab-s329.html